Φορτώνει......
Efficacy and safety of octreotide treatment for diazoxide‐unresponsive congenital hyperinsulinism in China
IMPORTANCE: Octreotide is an off‐label medicine for congenital hyperinsulinism (CHI), but is currently widely used for treatment of patients with CHI. Thus far, variable efficacy and adverse effects have been reported for octreotide. OBJECTIVE: The present study evaluated the efficacy and safety of...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Pediatr Investig |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7331369/ https://ncbi.nlm.nih.gov/pubmed/32851339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ped4.12175 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|